Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.01 | 11.72 |
PEG Ratio (TTM) | -0.03 | 1.20 |
P/S Ratio (TTM) | 0.76 | 4.51 |
P/B Ratio (TTM) | 1.41 | 2.91 |
P/FCF Ratio (TTM) | -1.23 | 25.30 |
Price to 5YR AVG Earnings Ratio | -0.10 | 29.68 |
Price to 5YR AVG FCF Ratio | -0.90 | 19.54 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -43.43% | 3.16% |
ROE (TTM) | -308.51% | 9.47% |
Net Profit Margin (TTM) | -71.33% | -16.19% |
ROIC 5YR AVG | 406.88% | 8.68% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 26.96% | 4.27% | 9.18% |
Revenue | 15.46% | 2,309.67% | 1,418.11% |
Net Income | 4.85% | -16.25% | -6.92% |
Cash Flow | -17.74% | -27.98% | -2.58% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.44 | 2.46 |
Quick Ratio (TTM) | 1.39 | 1.83 |
D/E Ratio (TTM) | 1.14 | -0.68 |
Interest Coverage (TTM) | -11.76 | 15.86 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 4.51 |
LTL to 5YR AVG FCF | -0.69 | 5.14 |
Shares Outstanding Growth 5YR AVG | 19.69% | 28.60% |